Ronald Hunt's Net Worth
Estimate Recalculated Dec 3, 2025 08:04PM EST
Who is Ronald Hunt
Ronald Hunt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Relypsa Inc, iRhythm Technologies, Inc., Rallybio Corp, Harpoon Therapeutics, Inc., Oxford Immunotec Global PLC, CONCERT PHARMACEUTICALS, INC., Iterum Therapeutics plc, Neuronetics, Inc., MEI Pharma, Inc., Transcept Pharmaceuticals Inc, Durata Therapeutics, Inc., Versartis, Inc., CHIMERIX INC, ICAGEN INC, WORLD HEART CORP, and CORIXA CORP.
SEC CIK
Ronald Hunt's CIK is 0001247851
Past Insider Trading and Trends
2023 was Ronald Hunt's most active year for acquiring shares with 11 total transactions. Ronald Hunt's most active month to acquire stocks was the month of April. 2024 was Ronald Hunt's most active year for disposing of shares, totalling 5 transactions. Ronald Hunt's most active month to dispose stocks was the month of February. 2024 saw Ronald Hunt paying a total of $51,499.92 for 47,092 shares, this is the most they've acquired in one year. In 2022 Ronald Hunt cashed out on 36,798 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
